Product Information
METHIMAZOLE 5 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0722 per EA under NDC 62135020518. Its NADAC has been published 229 times since Feb 9, 2022.
Strength
5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135020518
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA040411On Market Since
3/27/2001
Pharmacological Classes
Price Statistics
The NADAC for METHIMAZOLE 5 MG TABLET has been published 229 times since Feb 9, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0722 per EA |
|---|---|
| All-time high | $0.1140 (Sep 13, 2023) |
| All-time low | $0.0602 (May 18, 2022) |
| 52-week high | $0.0864 |
| 52-week low | $0.0718 |
| Median price | $0.0747 |
| Average price | $0.0782 |
| Largest weekly change | +27.3% (Aug 23, 2023) |
| Weeks tracked | 229 |
| Tracking since | Feb 9, 2022 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHIMAZOLE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHIMAZOLE 5 MG TABLET, manufactured by Chartwell RX LLC, is $0.0722 per EA (NDC 62135020518), effective Jun 24, 2026.
How has the price of METHIMAZOLE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHIMAZOLE 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 229 weekly CMS publications since Feb 9, 2022.
What are the highest and lowest recorded NADAC prices for METHIMAZOLE 5 MG TABLET?
Since Feb 9, 2022, the NADAC for METHIMAZOLE 5 MG TABLET has ranged from a low of $0.0602 (May 18, 2022) to a high of $0.1140 (Sep 13, 2023), with a median of $0.0747 per EA.
Are there cheaper alternatives to METHIMAZOLE 5 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as METHIMAZOLE 5 MG TABLET, but none are currently priced below it.
Who manufactures METHIMAZOLE 5 MG TABLET?
METHIMAZOLE 5 MG TABLET (NDC 62135020518) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification